The Future of Cervical Cancer Screening
- PMID: 39464249
- PMCID: PMC11512781
- DOI: 10.2147/IJWH.S474571
The Future of Cervical Cancer Screening
Abstract
Purpose: Cervical cancer remains a significant health concern, particularly in developing countries, where it is a leading cause of cancer-related deaths among women. Innovative technologies have emerged to improve the efficiency, cost-effectiveness, and sensitivity of cervical cancer screening and treatment methods. This study aims to explore the various approaches for the detection and treatment of human papillomavirus (HPV), cervical dysplasia (CD), and cervical cancer, highlighting new technologies and updated screening strategies in developing areas.
Patients and methods: A comprehensive literature search was conducted using PubMed to identify relevant publications on the subject of cervical cancer screening and HPV detection.
Results: HPV infection and cervical cancer continue to pose significant global health challenges. Emerging technologies such as rapid, low-cost HPV testing combined with high-resolution digital colposcopy and artificial intelligence interpretation hold promise for efficient and sensitive screening. Advancements in HPV vaccine distribution, high-risk HPV screening, DNA methylation assays, dual-stain cytology, lab-on-chip assays, and deep learning technologies offer new avenues for improved detection and risk stratification.Research and innovations in detection and treatment methods are crucial for reducing the burden of these diseases worldwide.
Conclusion: Screening for HPV and CD plays a pivotal role in reducing the risk of cervical cancer-related mortality. The development of novel technologies, along with efforts to enhance global health equity and integrate cervical cancer prevention with HIV screening and treatment programs, represent critical steps toward achieving comprehensive cervical cancer screening on a global scale.
Keywords: HPV self-swab; cervical automated visual evaluation; digital colposcope; human papillomavirus.
© 2024 Goldstein et al.
Conflict of interest statement
The author(s) report no conflicts of interest in this work.
Figures
Similar articles
-
Cervical Cancer Screening: Past, Present, and Future.Sex Med Rev. 2020 Jan;8(1):28-37. doi: 10.1016/j.sxmr.2019.09.005. Epub 2019 Nov 30. Sex Med Rev. 2020. PMID: 31791846 Review.
-
Anal dysplasia screening: an evidence-based analysis.Ont Health Technol Assess Ser. 2007;7(4):1-43. Epub 2007 Jun 1. Ont Health Technol Assess Ser. 2007. PMID: 23074504 Free PMC article.
-
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].Epidemiol Prev. 2012 May-Aug;36(3-4 Suppl 1):e1-72. Epidemiol Prev. 2012. PMID: 22828243 Italian.
-
Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.PLoS One. 2017 Jan 17;12(1):e0163509. doi: 10.1371/journal.pone.0163509. eCollection 2017. PLoS One. 2017. PMID: 28095411 Free PMC article.
-
Screening for cervical cancer: new alternatives and research.Salud Publica Mex. 2003;45 Suppl 3:S376-87. doi: 10.1590/s0036-36342003000900012. Salud Publica Mex. 2003. PMID: 14746031 Review.
Cited by
-
Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review.Ther Adv Vaccines Immunother. 2025 Jul 24;13:25151355251356646. doi: 10.1177/25151355251356646. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40718465 Free PMC article. Review.
-
N6-methyladenosine in cervical carcinogenesis: Mechanistic insights and therapeutic perspectives (Review).Oncol Lett. 2025 Jul 14;30(3):442. doi: 10.3892/ol.2025.15188. eCollection 2025 Sep. Oncol Lett. 2025. PMID: 40697345 Free PMC article. Review.
-
Genetic Biomarkers Associated with Dynamic Transitions of Human Papillomavirus (HPV) Infection-Precancerous-Cancer of Cervix for Navigating Precision Prevention.Int J Mol Sci. 2025 Jun 23;26(13):6016. doi: 10.3390/ijms26136016. Int J Mol Sci. 2025. PMID: 40649795 Free PMC article.
-
Prioritizing the risk of cervical cancer: findings from the SCCUT Multicentre Initiative.J Med Life. 2025 Jun;18(6):590-593. doi: 10.25122/jml-2025-0100. J Med Life. 2025. PMID: 40757110 Free PMC article.
-
Age-period-cohort analysis of global, regional, and national cervical cancer prevalence trends in women of childbearing age (15-49 years), 1990-2021.BMC Womens Health. 2025 Jul 28;25(1):374. doi: 10.1186/s12905-025-03918-6. BMC Womens Health. 2025. PMID: 40721776 Free PMC article.
References
-
- Organization GWH. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Published online 2021. doi:Licence: CC BY-NC-SA 3.0 IGO.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous